Merck & Co., Inc.
Rahway, New Jersey
Dr. James DiNunzio is currently a Senior Principal Scientist at Merck & Co., Inc. in Rahway, NJ where he heads the Hot-Melt Extrusion (HME) Subject Matter Expert Network Team and Continuous Processing Technology Development Team. Since joining Merck in 2013 he has contributed to multiple programs in the disease areas of oncology, virology and CNS disorders. Prior to Merck, he served as a Senior Scientist in the Pharmaceutical & Analytical R&D group at Roche where he was responsible for the formulation design of poorly soluble compounds using enabled technologies, and has held positions of increasing responsibility at PharmaForm and Forest Laboratories.
Dr. DiNunzio received his Ph.D. in Pharmacy (Pharmaceutics) from The University of Texas in 2009 specializing in thermal manufacturing of amorphous dispersions. He also holds M.S. and B.S. degrees in Chemical Engineering from Columbia University and SUNY Buffalo. He currently serves on the Editorial Advisory Boards of AAPS PharmSciTech and the Journal of Pharmaceutical Sciences. He has authored over 25 research papers and book chapters in the field of HME and formulation design for bioavailability enhancement. His current research interests include: formulation design for bioavailability enhancement, HME process design for challenging systems and the development of continuous manufacturing technologies.
Monday, November 4
1:30 PM – 2:30 PM